In April 2016 Manchester eScholar was replaced by the University of Manchester’s
new Research Information Management System, Pure. In the autumn the University’s research
outputs will be available to search and browse via a new Research Portal. Until then
the University’s full publication record can be accessed via a
temporary portal and the old eScholar content is available to search and browse via this archive.
Related resources
Full-text held externally
Search for item elsewhere
University researcher(s)
The clinically active PARP inhibitor AG014699 ameliorates cardiotoxicity but doesn’t enhance the efficacy of doxorubicin, despite improving tumour perfusion and radiation response in mice.
Majid Ali, Marzieh Kamjoo, Huw D Thomas, Suzanne Kyle, Ivanda Pavlovska, Muhammed Babur, Brian A Telfer, Nicola J Curtin and Kaye J Williams
Mol Cancer Therapeutics. 2011;10(12):2320-2329.
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Full-text is available externally using the following links:
Full-text held externally
Bibliographic metadata
Type of resource:
Content type:
Publication type:
Publication form:
Published date:
Journal title:
Volume:
10
Issue:
12
Start page:
2320
End page:
2329
Digital Object Identifier:
10.1158/1535-7163.MCT-11-0356
Access state:
Active
Institutional metadata
University researcher(s):
Academic department(s):
Record metadata
Manchester eScholar ID:
uk-ac-man-scw:140738
Created by:
Williams, Kaye
Created:
15th December, 2011, 14:57:13
Last modified by:
Williams, Kaye
Last modified:
10th March, 2014, 15:31:24